Properties of felodipine-poly(vinylpyrrolidone) solid dispersion films and the impact of solvents

ScienceAsia

Volumn 38, Issue 2, 2012, Pages 188-195

  Suknuntha, Krit ^a   Jones, David S ^b   Tantishaiyakul, Vimon ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Glass transition temperature; Solubility parameter; Solvent evaporation

Indexed keywords

EID: 84863980209     PISSN: 15131874     EISSN: None     Source Type: Journal    
DOI: 10.2306/scienceasia1513-1874.2012.38.188     Document Type: Article

References (28)

1. Serajuddin AT (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharmaceut Sci 88, 1058-66.
2. Dressman J, Reppas C (2007) Drug solubility: how to measure it, how to improve it. Adv Drug Deliv Rev 59, 531-2. (Pubitemid 47285411)
3. Law D, Krill SL, Schmitt EA, Fort JJ, Qiu Y, Wang W, Porter WR (2001) Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J Pharmaceut Sci 90, 1015-25.
4. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50, 47-60. (Pubitemid 30326688)
5. Sekikawa H, Nakano M, Arita T (1978) Inhibitory Effect of Polyvinylpyrrolidone on the Crystallization of Drugs. Chem Pharmaceut Bull 26, 118-26. (Pubitemid 8273726)
6. Crowley KJ, Zografi G (2003) The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state. Pharmaceut Res 20, 1417-22. (Pubitemid 37164050)
7. Taylor LS, Zografi G (1997) Spectroscopic characterization of interactions between pvp and indomethacin in amorphous molecular dispersions. Pharmaceut Res 14, 1691-8. (Pubitemid 28062912)
8. Miyazaki T, Yoshioka S, Aso Y, Kojima S (2004) Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J Pharmaceut Sci 93, 2710-7. (Pubitemid 39506621)
9. Paudel A, Humbeeck JV, Mooter GVd (2010) Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone). Mol Pharm 7, 1133-48.
10. Greenhalgh DJ, Williams AC, Timmins P, York P (1999) Solubility parameters as predictors of miscibility in solid dispersions. J Pharmaceut Sci 88, 1182-90. (Pubitemid 29526305)
11. Nair R, Nyamweya N, G̈onen S, Mart́inez-Miranda LJ, Hoag SW (2001) Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int J Pharm 225, 83-96. (Pubitemid 32728202)
12. Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharmaceut Sci 60, 1281-302.
13. Al-Obaidi H, Brocchini S, Buckton G (2009) Anomalous Properties of Spray Dried Solid Dispersions. J Pharmaceut Sci 98, 4724-37.
14. Konno H, Taylor L (2008) Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharmaceut Res 25, 969-78. (Pubitemid 351661822)
15. Kim E-J, Chun M-K, Jang J-S, Lee I-H, Lee K-R, Choi H-K (2006) Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm 64, 200-5. (Pubitemid 44291986)
16. Karavas E, Ktistis G, Xenakis A, Georgarakis E (2005) Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm 31, 473-89. (Pubitemid 41285726)
17. Jones DS, Medlicott NJ (1995) Casting solvent controlled release of chlorhexidine from ethylcellulose films prepared by solvent evaporation. Int J Pharm 114, 257-61. (Pubitemid 24375908)
18. Hansen CM (1969) The universality of the solubility parameter. Ind Eng Chem Prod Res Dev 8, 2-11.
19. Archer WL (1991) Determination of hansen solubility parameters for selected cellulose ether derivatives. Ind Eng Chem Res 30, 2292-8.
20. Archer WL (1992) Hansen solubility parameters for selected cellulose ether derivatives and their use in the pharmaceutical industry. Drug Dev Ind Pharm 18, 599-616.
21. Royall PG, Huang CY, Tang SW, Duncan J, Van-de- Velde G, Brown MB (2005) The development of DMA for the detection of amorphous content in pharmaceutical powdered materials. Int J Pharm 301, 181-91. (Pubitemid 41206602)
22. Rollinger JM, Burger A (2001) Polymorphism of racemic felodipine and the unusual series of solid solutions in the binary system of its enantiomers. J Pharmaceut Sci 90, 949-59. (Pubitemid 32645951)
23. Couchman PR, Karasz FE (1978) A classical thermodynamic discussion of the effect of composition on glass-transition temperatures. Macromolecules 11, 117-9.
24. Konno H, Taylor L (2006) Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharmaceut Sci 95, 2692-705. (Pubitemid 46093176)
25. Marsac P, Konno H, Rumondor A, Taylor L (2008) Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly (vinylpyrrolidone) and sorbed water. Pharmaceut Res 25, 647-56. (Pubitemid 351357733)
26. Honary S, Orafai H (2002) The effect of different plasticizer molecular weights and concentrations on mechanical and thermomechanical properties of free films. Drug Dev Ind Pharm 28, 711-5. (Pubitemid 34809571)
27. Jones DS (1999) Dynamic mechanical analysis of polymeric systems of pharmaceutical and biomedical significance. Int J Pharm 179, 167-78. (Pubitemid 29131429)
28. Prodduturi S, Urman KL, Otaigbe JU, Repka MA (2007) Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech 8, 152-61.